title: Nalmefene for alcohol dependence: a NICE decision?
authors.affiliation: Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Palo Alto, CA CA 94304, USA. Electronic address: floriannaudet@gmail.com.
authors.forename: Florian
authors.initials: F
authors.lastname: Naudet
authors.affiliation: Institute for Social Marketing, Faculty of Health Sciences and Sport, UK Centre for Tobacco and Alcohol Studies, Stirling, UK.
authors.forename: Niamh
authors.initials: N
authors.lastname: Fitzgerald
authors.affiliation: University hospital, Amiens, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Braillon
mesh_terms: D000437:Alcoholism / Q000188:drug therapy*; D006801:Humans; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D013222:State Medicine / Q000458:organization & administration*; D006113:United Kingdom
chemical_list: D009292:Narcotic Antagonists; D009271:Naltrexone; C038981:nalmefene